BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the remaining $35… BioAtla will receive an initial $5 milli...
Browsing Tag: Gatc
1
2
3
PAK ALERT NEWS
BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the remaining $35… BioAtla will receive an initial $5 milli...